AngioDynamics (ANGO) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

ANGO Stock Forecast

AngioDynamics stock forecast is as follows: an average price target of $13.00 (represents a 46.23% upside from ANGO’s last price of $8.89) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

ANGO Price Target

The average price target for AngioDynamics (ANGO) is $13.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $14.00 to $12.00. This represents a potential 46.23% upside from ANGO's last price of $8.89.

ANGO Analyst Ratings

Buy

According to 6 Wall Street analysts, AngioDynamics's rating consensus is 'Buy'. The analyst rating breakdown for ANGO stock is 0 'Strong Buy' (0.00%), 6 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

AngioDynamics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 04, 2024	William Plovanic	Canaccord Genuity	$12.00	$6.10	96.72%	34.98%
Sep 20, 2024	Yi Chen	H.C. Wainwright	$14.00	$7.70	81.82%	57.48%
Apr 05, 2024	Steven Lichtman	Oppenheimer	$12.00	$6.40	87.50%	34.98%
Jan 06, 2023		Raymond James	$22.00	$15.48	42.12%	147.47%
Jul 13, 2022		Raymond James	$27.00	$20.02	34.87%	203.71%

The latest AngioDynamics stock forecast, released on Oct 04, 2024 by William Plovanic from Canaccord Genuity, set a price target of $12.00, which represents a 96.72% increase from the stock price at the time of the forecast ($6.10), and a 34.98% increase from ANGO last price ($8.89).

AngioDynamics Price Target by Period

	1M	3M	12M
# Anlaysts	-	2	3
Avg Price Target	-	$13.00	$12.67
Last Closing Price	$8.89	$8.89	$8.89
Upside/Downside	-100.00%	46.23%	42.52%

In the current month, the average price target of AngioDynamics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to AngioDynamics's last price of $8.89. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 04, 2024	Oppenheimer	Outperform	Outperform	Hold
Oct 04, 2024	William Blair	Buy	Buy	Hold
Oct 04, 2024	Canaccord Genuity	Buy	Buy	Hold
Oct 03, 2024	Raymond James	Outperform	Outperform	Hold
Sep 20, 2024	H.C. Wainwright	Buy	Buy	Hold
Apr 05, 2024	Oppenheimer		Outperform	Upgrade
Jan 09, 2024	Raymond James	Outperform	Outperform	Hold
Jan 08, 2024	Jefferies	Buy	Buy	Hold
Oct 06, 2023	Raymond James	Outperform	Outperform	Hold
Jan 06, 2023	Raymond James	Strong Buy	Strong Buy	Hold
Jul 13, 2022	Raymond James	Strong Buy	Strong Buy	Hold

AngioDynamics's last stock rating was published by Oppenheimer on Oct 04, 2024. The company gave ANGO a "Outperform" rating, the same as its previous rate.

AngioDynamics Financial Forecast

AngioDynamics Revenue Forecast

	May 26	Mar 26	Dec 25	Aug 25	May 25	Mar 25	Dec 24	Aug 24	May 24	Mar 24	Dec 23	Aug 23	May 23	Mar 23	Dec 22	Aug 22	May 22	Mar 22	Dec 21	Aug 21	May 21	Mar 21	Dec 20	Aug 20	May 20	Mar 20	Dec 19	Aug 19	May 19	Mar 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	$78.68M	$91.07M	-	-	$81.54M	$87.00M	-	-	$76.97M	$76.84M	-	-	$70.22M	$58.33M	-	-	$66.04M	$7.45M	-
Avg Forecast	$79.55M	$75.35M	$75.90M	$72.65M	$74.86M	$70.57M	$70.93M	$67.93M	$70.86M	$74.21M	$81.16M	$77.70M	$90.73M	$83.19M	$153.09M	$83.43M	$82.92M	$76.32M	$77.91M	$71.30M	$72.67M	$68.95M	$67.35M	$65.11M	$62.86M	$68.55M	$71.27M	$67.74M	$92.33M	$88.30M
High Forecast	$79.93M	$75.71M	$76.27M	$73.00M	$75.23M	$70.82M	$71.26M	$67.93M	$71.20M	$74.21M	$82.20M	$78.08M	$91.17M	$83.60M	$183.71M	$83.87M	$83.35M	$76.73M	$78.32M	$71.68M	$73.06M	$69.31M	$67.70M	$65.45M	$63.19M	$68.91M	$71.65M	$68.10M	$92.82M	$88.77M
Low Forecast	$79.20M	$75.02M	$75.57M	$72.33M	$74.54M	$70.32M	$70.66M	$67.93M	$70.55M	$74.21M	$79.88M	$77.36M	$90.34M	$82.83M	$122.47M	$82.99M	$82.48M	$75.92M	$77.50M	$70.92M	$72.29M	$68.58M	$66.99M	$64.77M	$62.53M	$68.19M	$70.90M	$67.38M	$91.85M	$87.83M
# Analysts	1	1	1	1	1	3	3	1	2	2	4	2	7	13	15	1	1	1	2	2	2	2	9	11	15	18	8	8	8	10
Surprise %	-	-	-	-	-	-	-	-	-	-	-	1.01%	1.00%	-	-	0.98%	1.05%	-	-	1.08%	1.06%	-	-	1.08%	0.93%	-	-	0.97%	0.08%	-

AngioDynamics's average Quarter revenue forecast for Dec 23 based on 4 analysts is $81.16M, with a low forecast of $79.88M, and a high forecast of $82.20M. ANGO's average Quarter revenue forecast represents a 3.15% increase compared to the company's last Quarter revenue of $78.68M (Aug 23).

AngioDynamics EBITDA Forecast

	May 26	Mar 26	Dec 25	Aug 25	May 25	Mar 25	Dec 24	Aug 24	May 24	Mar 24	Dec 23	Aug 23	May 23	Mar 23	Dec 22	Aug 22	May 22	Mar 22	Dec 21	Aug 21	May 21	Mar 21	Dec 20	Aug 20	May 20	Mar 20	Dec 19	Aug 19	May 19	Mar 19
# Analysts	1	1	1	1	1	3	3	1	2	2	4	2	7	13	15	1	1	1	2	2	2	2	9	11	15	18	8	8	8	10
EBITDA	-	-	-	-	-	-	-	-	-	-	-	$35.03M	$5.00M	-	-	$-24.00K	$3.33M	-	-	$-1.46M	$-15.23M	-	-	$1.98M	$-150.42M	-	-	$4.28M	$-9.90M	-
Avg Forecast	$-8.76M	$-8.30M	$-8.36M	$-8.00M	$-8.24M	$-7.77M	$-7.81M	$-7.48M	$-7.80M	$13.12M	$-8.94M	$-8.56M	$-9.99M	$10.37M	$3.15M	$2.03M	$2.01M	$8.20M	$1.89M	$1.73M	$1.77M	$6.69M	$1.64M	$1.58M	$1.53M	$153.30K	$1.73M	$1.65M	$2.24M	$10.67M
High Forecast	$-8.72M	$-8.26M	$-8.32M	$-7.96M	$-8.21M	$-7.74M	$-7.78M	$-7.48M	$-7.77M	$15.74M	$-8.79M	$-8.52M	$-9.95M	$12.45M	$3.78M	$2.04M	$2.02M	$9.84M	$1.90M	$1.74M	$1.77M	$8.03M	$1.64M	$1.59M	$1.53M	$183.96K	$1.74M	$1.65M	$2.25M	$12.80M
Low Forecast	$-8.80M	$-8.34M	$-8.40M	$-8.04M	$-8.28M	$-7.80M	$-7.85M	$-7.48M	$-7.84M	$10.50M	$-9.05M	$-8.60M	$-10.04M	$8.30M	$2.52M	$2.02M	$2.00M	$6.56M	$1.88M	$1.72M	$1.76M	$5.35M	$1.63M	$1.57M	$1.52M	$122.64K	$1.72M	$1.64M	$2.23M	$8.53M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-4.09%	-0.50%	-	-	-0.01%	1.65%	-	-	-0.84%	-8.63%	-	-	1.25%	-98.51%	-	-	2.60%	-4.42%	-

4 analysts predict ANGO's average Quarter EBITDA for Dec 23 to be $-8.94M, with a high of $-8.79M and a low of $-9.05M. This is -125.51% lower than AngioDynamics's previous annual EBITDA (Aug 23) of $35.03M.

AngioDynamics Net Income Forecast

	May 26	Mar 26	Dec 25	Aug 25	May 25	Mar 25	Dec 24	Aug 24	May 24	Mar 24	Dec 23	Aug 23	May 23	Mar 23	Dec 22	Aug 22	May 22	Mar 22	Dec 21	Aug 21	May 21	Mar 21	Dec 20	Aug 20	May 20	Mar 20	Dec 19	Aug 19	May 19	Mar 19
# Analysts	1	1	1	1	1	3	3	1	2	2	4	2	7	13	15	1	1	1	2	2	2	2	9	11	15	18	8	8	8	10
Net Income	-	-	-	-	-	-	-	-	-	-	-	$45.88M	$-21.47M	-	-	$-13.00M	$-6.27M	-	-	$-6.97M	$-19.47M	-	-	$-4.27M	$-157.07M	-	-	$-1.27M	$-13.61M	-
Avg Forecast	$-609.79K	$-2.24M	$-2.03M	$-3.86M	$-2.98M	$-4.61M	$-4.47M	$-5.96M	$-6.78M	$-35.70M	$-3.00M	$-5.28M	$876.07K	$-28.22M	$-8.98M	$-914.69K	$304.90K	$-22.31M	$76.90M	$-1.83M	$-135.50K	$-9.57M	$-813.06K	$-2.71M	$-2.30M	$-11.99M	$948.56K	$1.73M	$10.37M	$904.54K
High Forecast	$-606.34K	$-2.22M	$-2.02M	$-3.84M	$-2.96M	$-4.58M	$-4.07M	$-5.93M	$-6.74M	$-28.56M	$-2.00M	$-5.25M	$881.58K	$-22.58M	$-7.18M	$-908.40K	$306.99K	$-17.85M	$77.43M	$-1.82M	$-134.56K	$-7.66M	$-807.47K	$-2.69M	$-2.29M	$-9.59M	$955.08K	$1.74M	$10.44M	$1.09M
Low Forecast	$-613.63K	$-2.25M	$-2.05M	$-3.89M	$-3.00M	$-4.64M	$-4.88M	$-6.00M	$-6.82M	$-42.84M	$-3.66M	$-5.32M	$871.10K	$-33.87M	$-10.77M	$-920.98K	$302.80K	$-26.77M	$76.37M	$-1.84M	$-136.43K	$-11.48M	$-818.65K	$-2.73M	$-2.32M	$-14.39M	$942.03K	$1.72M	$10.30M	$723.64K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-8.68%	-24.50%	-	-	14.22%	-20.55%	-	-	3.81%	143.68%	-	-	1.57%	68.18%	-	-	-0.74%	-1.31%	-

AngioDynamics's average Quarter net income forecast for Dec 23 is $-3.00M, with a range of $-3.66M to $-2.00M. ANGO's average Quarter net income forecast represents a -106.53% decrease compared to the company's last Quarter net income of $45.88M (Aug 23).

AngioDynamics SG&A Forecast

	May 26	Mar 26	Dec 25	Aug 25	May 25	Mar 25	Dec 24	Aug 24	May 24	Mar 24	Dec 23	Aug 23	May 23	Mar 23	Dec 22	Aug 22	May 22	Mar 22	Dec 21	Aug 21	May 21	Mar 21	Dec 20	Aug 20	May 20	Mar 20	Dec 19	Aug 19	May 19	Mar 19
# Analysts	1	1	1	1	1	3	3	1	2	2	4	2	7	13	15	1	1	1	2	2	2	2	9	11	15	18	8	8	8	10
SG&A	-	-	-	-	-	-	-	-	-	-	-	$38.22M	$36.52M	-	-	$36.64M	$37.94M	-	-	$33.39M	$32.95M	-	-	$26.26M	$26.43M	-	-	$27.83M	$26.00M	-
Avg Forecast	$34.47M	$32.65M	$32.89M	$31.48M	$32.44M	$30.58M	$30.73M	$29.43M	$30.70M	$32.15M	$35.16M	$33.67M	$39.31M	$36.05M	$61.84M	$36.09M	$35.87M	$33.02M	$33.70M	$30.84M	$31.44M	$29.82M	$29.13M	$28.17M	$27.19M	$65.39M	$30.83M	$29.30M	$39.94M	$32.04M
High Forecast	$34.63M	$32.81M	$33.05M	$31.63M	$32.59M	$30.68M	$30.88M	$29.43M	$30.85M	$32.15M	$35.62M	$33.83M	$39.50M	$36.22M	$74.20M	$36.28M	$36.06M	$33.19M	$33.88M	$31.01M	$31.60M	$29.98M	$29.29M	$28.31M	$27.34M	$78.47M	$30.99M	$29.46M	$40.15M	$38.44M
Low Forecast	$34.32M	$32.51M	$32.74M	$31.34M	$32.30M	$30.47M	$30.62M	$29.43M	$30.57M	$32.15M	$34.61M	$33.52M	$39.14M	$35.89M	$49.47M	$35.90M	$35.68M	$32.84M	$33.52M	$30.68M	$31.27M	$29.67M	$28.98M	$28.02M	$27.05M	$52.31M	$30.67M	$29.15M	$39.73M	$25.63M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	1.14%	0.93%	-	-	1.02%	1.06%	-	-	1.08%	1.05%	-	-	0.93%	0.97%	-	-	0.95%	0.65%	-

AngioDynamics's average Quarter SG&A projection for Dec 23 is $35.16M, based on 4 Wall Street analysts, with a range of $34.61M to $35.62M. The forecast indicates a -8.00% fall compared to ANGO last annual SG&A of $38.22M (Aug 23).

AngioDynamics EPS Forecast

	May 26	Mar 26	Dec 25	Aug 25	May 25	Mar 25	Dec 24	Aug 24	May 24	Mar 24	Dec 23	Aug 23	May 23	Mar 23	Dec 22	Aug 22	May 22	Mar 22	Dec 21	Aug 21	May 21	Mar 21	Dec 20	Aug 20	May 20	Mar 20	Dec 19	Aug 19	May 19	Mar 19
# Analysts	1	1	1	1	1	3	3	1	2	2	4	2	7	13	15	1	1	1	2	2	2	2	9	11	15	18	8	8	8	10
EPS	-	-	-	-	-	-	-	-	-	-	-	$1.15	$-0.54	-	-	$-0.33	$-0.16	-	-	$-0.18	$-0.51	-	-	$-0.11	$-4.10	-	-	$-0.03	$1.57	-
Avg Forecast	$-0.01	$-0.06	$-0.05	$-0.10	$-0.07	$-0.11	$-0.11	$-0.15	$-0.17	$-0.15	$-0.07	$-0.13	$0.02	$-0.01	$1.95	$-0.02	$0.01	$-0.01	$1.89	$-0.04	$-0.00	$-0.02	$-0.02	$-0.07	$-0.06	$-0.03	$0.02	$0.04	$0.26	$0.21
High Forecast	$-0.01	$-0.05	$-0.05	$-0.09	$-0.07	$-0.11	$-0.10	$-0.15	$-0.17	$-0.15	$-0.05	$-0.13	$0.02	$-0.01	$1.97	$-0.02	$0.01	$-0.01	$1.90	$-0.04	$-0.00	$-0.02	$-0.02	$-0.07	$-0.06	$-0.03	$0.02	$0.04	$0.26	$0.22
Low Forecast	$-0.02	$-0.06	$-0.05	$-0.10	$-0.07	$-0.11	$-0.12	$-0.15	$-0.17	$-0.16	$-0.09	$-0.13	$0.02	$-0.01	$1.94	$-0.02	$0.01	$-0.01	$1.88	$-0.05	$-0.00	$-0.02	$-0.02	$-0.07	$-0.06	$-0.03	$0.02	$0.04	$0.25	$0.21
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-8.85%	-25.06%	-	-	14.67%	-21.33%	-	-	4.00%	153.02%	-	-	1.65%	72.35%	-	-	-0.71%	6.16%	-

According to 4 Wall Street analysts, AngioDynamics's projected average Quarter EPS for Dec 23 is $-0.07, with a low estimate of $-0.09 and a high estimate of $-0.05. This represents a -106.41% decrease compared to ANGO previous annual EPS of $1.15 (Aug 23).

AngioDynamics Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
AKYA	Akoya Biosciences	$2.54	$4.83	90.16%	Buy
ANGO	AngioDynamics	$9.26	$13.00	40.39%	Buy
HAE	Haemonetics	$82.07	$107.00	30.38%	Buy
ATRC	AtriCure	$31.50	$39.67	25.94%	Buy
ATR	AptarGroup	$163.09	$200.00	22.63%	Buy
COO	Cooper Companies	$94.49	$115.00	21.71%	Buy
ICUI	ICU Medical	$157.17	$190.50	21.21%	Buy
MMSI	Merit Medical Systems	$99.00	$108.83	9.93%	Buy
NVST	Envista	$19.24	$20.29	5.46%	Hold
KRMD	KORU Medical Systems	$4.12	$3.25	-21.12%	Buy

ANGO Forecast FAQ

Is AngioDynamics a good buy?

Yes, according to 6 Wall Street analysts, AngioDynamics (ANGO) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 100.00% of ANGO's total ratings.

What is ANGO's price target?

AngioDynamics (ANGO) average price target is $13 with a range of $12 to $14, implying a 46.23% from its last price of $8.89. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will AngioDynamics stock go up soon?

According to Wall Street analysts' prediction for ANGO stock, the company can go up by 46.23% (from the last price of $8.89 to the average price target of $13), up by 57.48% based on the highest stock price target, and up by 34.98% based on the lowest stock price target.

Can AngioDynamics stock reach $13?

ANGO's highest twelve months analyst stock price target of $14 supports the claim that AngioDynamics can reach $13 in the near future.

What are AngioDynamics's analysts' financial forecasts?

AngioDynamics's analysts financial forecasts for the fiscal year (May 2025) are as follows: average revenue is $284.3M (high $285.24M, low $283.45M), average EBITDA is $-31.304M (high $-31.21M, low $-31.407M), average net income is $-18.023M (high $-17.54M, low $-18.514M), average SG&A $123.18M (high $123.59M, low $122.82M), and average EPS is $-0.443 (high $-0.431, low $-0.455). ANGO's analysts financial forecasts for the fiscal year (May 2026) are as follows: average revenue is $303.45M (high $304.92M, low $302.13M), average EBITDA is $-33.412M (high $-33.267M, low $-33.574M), average net income is $-8.74M (high $-8.691M, low $-8.795M), average SG&A $131.48M (high $132.12M, low $130.91M), and average EPS is $-0.215 (high $-0.214, low $-0.216).

Did the ANGO's actual financial results beat the analysts' financial forecasts?

Based on AngioDynamics's last annual report (May 2023), the company's revenue was $338.75M, which missed the average analysts forecast of $410.45M by -17.47%. Apple's EBITDA was $11.64M, beating the average prediction of $5.56M by 109.39%. The company's net income was $-52.442M, beating the average estimation of $-37.241M by 40.82%. Apple's SG&A was $144.25M, missing the average forecast of $173.29M by -16.76%. Lastly, the company's EPS was $-1.33, missing the average prediction of $1.95 by -168.36%. In terms of the last quarterly report (Aug 2023), AngioDynamics's revenue was $78.68M, beating the average analysts' forecast of $77.7M by 1.26%. The company's EBITDA was $35.03M, missing the average prediction of $-8.555M by -509.45%. AngioDynamics's net income was $45.88M, missing the average estimation of $-5.285M by -968.21%. The company's SG&A was $38.22M, beating the average forecast of $33.67M by 13.54%. Lastly, the company's EPS was $1.15, missing the average prediction of $-0.13 by -984.62%